INOVELON 40 mg/ml, oral suspension bottle, 460 ml
Active ingredients: Rufinamide
Commercialized according to BDPMDispensing in France: Prescription only
Oral suspensionbottle, 460 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- INOVELON 40 mg/ml, suspension buvable
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polytéréphtalate (PET) avec fermeture de sécurité enfant de 460 ml avec seringue(s) pour administration orale avec adaptateur(s) pour flacon
- Marketing authorisation holder
- EISAI (ROYAUME-UNI)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 Apr 2013
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62205873CIP72206912CIP133400922069128Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RUFINAMIDEsuspension | 40 mg · 1 ml de suspension | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.